文献速递前列腺癌

软件辅助系统穿刺在阴性前列腺MRI患者中提高临床显著前列腺癌检出率

Improved Detection of Clinically Significant Prostate Cancer With Software-assisted Systematic Biopsy Using MR/US Fusion in Patients With Negative Prostate MRI.
PubMed 文献 · Urology · 2018-06-27

该研究比较了经直肠超声引导穿刺(TRUSGB)与基于磁共振/超声融合的软件辅助系统穿刺(SASB)在初次穿刺且多参数磁共振(mpMRI)阴性的患者中检出临床显著前列腺癌(Gleason≥7)的差异。

要点

  • 对于mpMRI阴性的初次穿刺患者,SASB较TRUSGB显著提高临床显著前列腺癌检出率。
  • SASB通过软件配准MRI与超声图像优化穿刺针分布,可能改善检出效果。

核心结论

  • 在初次穿刺且mpMRI阴性的患者中,SASB与更高的临床显著前列腺癌检出率相关。

主要发现

  • 两组基线特征相似。

关键数值与推荐

  • 临床显著前列腺癌定义为Gleason评分7分或以上。

临床怎么用

  • 对于mpMRI阴性的初次穿刺患者,可考虑采用软件辅助系统穿刺以提高临床显著前列腺癌的检出。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare detection rates of clinically significant prostate cancer (Gleason 7 or above) between standard transrectal ultrasound guided biopsy (TRUSGB) and software-assisted systematic biopsy (SASB) using magnetic resonance/ultrasound fusion in the setting of negative multiparametric magnetic resonance imaging (mpMRI) in biopsy-naïve patients. METHODS: We reviewed our prospectively maintained database of consecutive men that underwent prostate biopsy following mpMRI from September 2015 to December 2016. Patients with no prior biopsy (ie, biopsy naïve) whose mpMRI demonstrated no targetable lesions were included. Patients underwent either TRUSGB (n = 23) or SASB (n = 29). SASB was performing using the MRI/US fusion systematic template. Prebiopsy data were collected, and the detection rate of clinically significant prostate cancer was compared between biopsy approaches. RESULTS: Baseline patient characteristics were similar between the TRUSGB and SASB groups. Clinically significant prostate cancer was found in no patients undergoing TRUSGB and in 6 patients undergoing SASB (0 vs 21%, P = .028). CONCLUSION: Based on our institutional experience, SASB is associated with a higher detection rate of clinically significant prostate cancer when compared to TRUSGB for biopsy-naïve patients with negative prostate mpMRI. Software co-registration of the MRI and ultrasound image may optimize the distribution of biopsy cores allowing for improved prostate cancer detection compared to conventional TRUSGB.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Meng Y, Vetter JM, Parker AA, et al. Improved Detection of Clinically Significant Prostate Cancer With Software-assisted Systematic Biopsy Using MR/US Fusion in Patients With Negative Prostate MRI. Urology. 2018. PMID: 29958965. doi:10.1016/j.urology.2018.06.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。